Position statement: LEPROSY: Diagnosis, treatment and follow‐up
Authors:
- 3 April 2019
- journal article
- research article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 33 (7) , 1205-1213
Abstract
Background: Leprosy or Hansen's disease is a chronic infection caused by Mycobacterium leprae (M. leprae) or Mycobacterium lepromatosis (M. lepromatosis). In Europe, most of the leprosy cases are imported. However, occasionally a case is diagnosed in one of the old endemic foci. Leprosy is often not suspected because it is no longer emphasized in the medical curricula. Attention shifted from leprosy to tuberculosis and human immunodeficiency virus infections in the late 20th century, whereby the WHO leprosy programme was toned down in the conviction that leprosy was all but eliminated. The result of unawareness is a harmful doctor's delay.Material and methods: This paper focusses on clinical diagnosis, complications and treatment based on literature and experience.Results: It mentions the value of laboratory tests in classification, follow‐up and detection of relapses. It discusses the etiopathology.Conclusion: This is a position statement.Keywords
This publication has 31 references indexed in Scilit:
- The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study)BMC Infectious Diseases, 2013
- Borderline Lepromatous Leprosy in an Italian ManThe American Journal of Tropical Medicine and Hygiene, 2013
- Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta‐analysisTropical Medicine & International Health, 2011
- The Diarylquinoline R207910 Is Bactericidal against Mycobacterium leprae in Mice at Low Dose and Administered IntermittentlyAntimicrobial Agents and Chemotherapy, 2009
- Hansen's disease in a general hospital: uncommon presentations and delay in diagnosisJournal of the European Academy of Dermatology and Venereology, 2009
- Thalidomide Suppressed IL-1β While Enhancing TNF-α and IL-10, When Cells in Whole Blood were Stimulated with LipopolysaccharideImmunopharmacology and Immunotoxicology, 2008
- Improving on BCGAPMIS, 1991
- EVIDENCE FOR PREVENTION OF BORDERLINE LEPROSY REACTIONS BY DAPSONEThe Lancet, 1976
- COMPARISON OF THE MODES OF SPREAD AND THE INCIDENCE OF TUBERCULOSIS AND LEPROSYThe Lancet, 1974
- The Promin Treatment of Leprosy. A Progress ReportPublic Health Reports®, 1943